ArticleNPJ precision oncology2022

Baseline gene expression profiling determines long-term benefit to programmed cell death protein 1 axis blockade.

Ioannis A Vathiotis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.